Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
August 21, 2017

(Market Call Minute) We are a seeing a turnaround.

Show full opinionHide full opinion
Novo-Nordisk (NVO-N)
August 21, 2017

(Market Call Minute) We are a seeing a turnaround.

DON'T BUY
DON'T BUY
August 21, 2017

(Market Call Minute) Avoid theatre operators because they are getting pushed out because people will download and watch at home.

Show full opinionHide full opinion

(Market Call Minute) Avoid theatre operators because they are getting pushed out because people will download and watch at home.

PARTIAL SELL
PARTIAL SELL
August 21, 2017

(Market Call Minute) It had a great run up and you should take at least half profits. The growth may not be there in the future.

Show full opinionHide full opinion

(Market Call Minute) It had a great run up and you should take at least half profits. The growth may not be there in the future.

TOP PICK
TOP PICK
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

Show full opinionHide full opinion
Coloplast A/S (COLOB-DC)
August 21, 2017

Colostomy bags. The demographics are such that gastrointestinal disorders are among the bigger problems dealing with the retirees of the world. If you get a company this size growing this fast without acquisitions you have a good company. They have a history of dividend increases. (Analysts’ target: DKK 553.00).

TOP PICK
TOP PICK
August 21, 2017

Comparing them to JNJ-N, SYK-N is blowing them out of the water. They are doing 3D printers to create products where bone can grow back. Dividend growth is in the 20% range. (Analysts’ target: US$156.00).

Show full opinionHide full opinion
Stryker Corp. (SYK-N)
August 21, 2017

Comparing them to JNJ-N, SYK-N is blowing them out of the water. They are doing 3D printers to create products where bone can grow back. Dividend growth is in the 20% range. (Analysts’ target: US$156.00).

TOP PICK
TOP PICK
August 21, 2017

Competes with IBM on business management software. Artificial Intelligence, data mining and cyber security come into the picture. It is a cheap stock at a price that is worth getting into. They are becoming a game changer. (Analysts’ target: $40.00).

Show full opinionHide full opinion
Open Text (OTEX-T)
August 21, 2017

Competes with IBM on business management software. Artificial Intelligence, data mining and cyber security come into the picture. It is a cheap stock at a price that is worth getting into. They are becoming a game changer. (Analysts’ target: $40.00).